{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:36:15Z","timestamp":1777642575738,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.pathol.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:54:27Z","timestamp":1752573267000},"page":"780-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial susceptibility testing and clinical outcomes of non-cystic fibrosis Burkholderia cepacia complex infections"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-7281","authenticated-orcid":false,"given":"Jinghao Nicholas","family":"Ngiam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7374-8207","authenticated-orcid":false,"given":"Matthew Chung Yi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patsy","family":"Soh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-6434","authenticated-orcid":false,"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pathol.2025.05.006_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcf.2022.10.005","article-title":"New concepts in antimicrobial resistance in cystic fibrosis respiratory infections","volume":"21","author":"Drevinek","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.pathol.2025.05.006_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2018.10.008","article-title":"Epidemiological investigation and successful management of a Burkholderia cepacia outbreak in a neurotrauma intensive care unit","volume":"79","author":"Rastogi","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.pathol.2025.05.006_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","article-title":"Antibiotic resistance in Burkholderia species","volume":"28","author":"Rhodes","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.pathol.2025.05.006_bib4","series-title":"Guidance document: antimicrobial susceptibility testing of Burkholderia cepacia complex (BCC)","year":"2013"},{"key":"10.1016\/j.pathol.2025.05.006_bib5","article-title":"Evaluation of susceptibility testing methods for Burkholderia cepacia complex: a comparison of broth microdilution, agar dilution, gradient strip and EUCAST disc diffusion","author":"Wootton","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.pathol.2025.05.006_bib6","series-title":"M100: performance standards for antimicrobial susceptibility testing","year":"2023"},{"issue":"12","key":"10.1016\/j.pathol.2025.05.006_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01447-21","article-title":"Evaluation of antimicrobial susceptibility testing methods for Burkholderia cenocepacia and Burkholderia multivorans isolates from cystic fibrosis patients","volume":"59","author":"Huse","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.pathol.2025.05.006_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1469-0691.12651","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"20","author":"Macia","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.pathol.2025.05.006_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/3352135","article-title":"Carbapenem-resistant Burkholderia cepacia complex isolates carrying blaNDM\u22121 and blaNDM\u22125 in ventilator-associated pneumonia patients and contaminated ventilator tubing","volume":"2024","author":"Saeed","year":"2024","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.pathol.2025.05.006_bib10","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant Gram-negative infections","volume":"18","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525002193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302525002193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:23:32Z","timestamp":1777443812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302525002193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0031302525002193"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2025.05.006","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility testing and clinical outcomes of non-cystic fibrosis Burkholderia cepacia complex infections","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2025.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}